Venus Medtech (Hangzhou) Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was CNY 491.37 million compared to CNY 406.46 million a year ago. Net loss was CNY 720.88 million compared to CNY 1,057.7 million a year ago.

Basic loss per share from continuing operations was CNY 1.65 compared to CNY 2.42 a year ago. Diluted loss per share from continuing operations was CNY 1.65 compared to CNY 2.42 a year ago.